Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | ALPG | P10696 | 1/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL30365140 | 0.98 | KDM4E (0.44) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| Hydrochloric Acid SCHEMBL27492797 | 0.98 | KDM4E (0.48) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| SCHEMBL12938337 | 0.90 | KDM4E (0.50) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| SCHEMBL13592680 | 0.89 | KDM4E (0.54) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| SCHEMBL13380707 | 0.89 | KDM4E (0.54) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| Hydrochloric Acid SCHEMBL4650870 | 0.89 | KDM4E (0.54) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| SCHEMBL6878412 | 0.84 | KDM4E (0.44) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| Hydrochloric Acid SCHEMBL542557 | 0.82 | ALDH1A1 (0.47) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| SCHEMBL544197 | 0.82 | MAPT (0.47) | KDM4EALDH1A1TDP1DNM1MEN1 | |
| SCHEMBL2349990 | 0.81 | DNM1 (0.50) | KDM4EALDH1A1TDP1DNM1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4165097-B1 | AQUEOUS POLYURETHANE RESIN DISPERSION | AGFA NV (BE) | 2024-03-20 | — | — | EP | disclosed |
| EP-4165097-A1 | AQUEOUS POLYURETHANE RESIN DISPERSION | AGFA NV (BE) | 2023-04-19 | — | — | EP | disclosed |
| US-9650595-B2 | Quaternary ammonium hydroxides | SACHEM, INC. (US) | 2017-05-16 | — | — | US | disclosed |
| US-9650595-B2 | Quaternary ammonium hydroxides | SACHEM, INC. (US) | 2017-05-16 | — | — | US | disclosed |
| US-20150329475-A1 | QUATERNARY AMMONIUM HYDROXIDES | SACHEM, INC. | 2015-11-19 | — | — | US | disclosed |
| US-20150329475-A1 | QUATERNARY AMMONIUM HYDROXIDES | SACHEM, INC. | 2015-11-19 | — | — | US | disclosed |
| US-9090859-B2 | Quaternary ammonium hydroxides | SACHEM, INC. (US) | 2015-07-28 | — | — | US | disclosed |
| US-20130261039-A1 | QUATERNARY AMMONIUM HYDROXIDES | SACHEM, INC. (US) | 2013-10-03 | — | — | US | disclosed |
| US-20130261039-A1 | QUATERNARY AMMONIUM HYDROXIDES | SACHEM, INC. (US) | 2013-10-03 | — | — | US | disclosed |
| US-20120295204-A1 | PROCESSING METHOD OF LITHOGRAPHIC PRINTING PLATE PREURSOR | FUJIFILM CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20090148793-A1 | PROCESSING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20090148793-A1 | PROCESSING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20090148792-A1 | METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE AND LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20080268372-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080268372-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080261153-A1 | PLATE MAKING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2008-10-23 | — | — | US | disclosed |
| US-20080261153-A1 | PLATE MAKING METHOD OF LITHOGRAPHIC PRINTING PLATE PRECURSOR | FUJIFILM CORPORATION (JP) | 2008-10-23 | — | — | US | disclosed |
| US-7312208-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203115-A1 | Novel quaternary ammonium compounds | SLC10A2, SLC10A1, ABCB11 | KDM4E 3284/4885ALDH1A1 2165/4885TDP1 4134/4885 |
| US-20150329475-A1 | QUATERNARY AMMONIUM HYDROXIDES | ASPH, AQP1, ATP1A2 | KDM4E 1030/4885ALDH1A1 1592/4885TDP1 1243/4885 |
| US-20130261039-A1 | QUATERNARY AMMONIUM HYDROXIDES | ASPH, ASNS, AQP1 | KDM4E 783/4885ALDH1A1 1872/4885TDP1 1293/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | KDM4E 1627/4885ALDH1A1 680/4885TDP1 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.